Physician profile
Abhner Wang
NPI 1780661298
$568.81
in general payments reported to CMS, 2019-2025
8 companies · $372 in 2025
The $372 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.93 · 2021: $32.44 · 2022: $35.25 · 2023: $70.26 · 2024: $30.27 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $472.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $198.75 | 2021-2025 | Precision 1 |
| Tarsus Pharmaceuticals, INC. | $154.73 | 2025 | Xdemvy |
| Coopervision INC. | $103.70 | 2023-2025 | Misight Contact Lens, Biofinity Contact Lens, Myday Contact Lens |
| Sun Pharmaceutical Industries INC. | $28.93 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $25.56 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $23.29 | 2022 | |
| Allergan, INC. | $19.43 | 2021 | |
| Lkc Technologies, INC. | $14.42 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abhner Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.